Virtus Fund Advisers’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$537K Hold
5,555
0.01% 323
2017
Q3
$494K Hold
5,555
0.01% 288
2017
Q2
$400K Hold
5,555
﹤0.01% 332
2017
Q1
$362K Hold
5,555
﹤0.01% 362
2016
Q4
$348K Hold
5,555
﹤0.01% 374
2016
Q3
$350K Buy
5,555
+1,723
+45% +$112K ﹤0.01% 377
2016
Q2
$240K Hold
3,832
﹤0.01% 387
2016
Q1
$219K Buy
3,832
+707
+23% +$39.4K ﹤0.01% 395
2015
Q4
$185K Hold
3,125
﹤0.01% 383
2015
Q3
$170K Hold
3,125
﹤0.01% 374
2015
Q2
$210K Buy
3,125
+302
+11% +$19.7K ﹤0.01% 388
2015
Q1
$165K Sell
2,823
-1,838
-39% -$111K ﹤0.01% 421
2014
Q4
$305K Hold
4,661
﹤0.01% 412
2014
Q3
$269K Sell
4,661
-14,192
-75% -$788K ﹤0.01% 446
2014
Q2
$1.06M Buy
+18,853
New +$989K 0.01% 442

Other funds holding ABBV

Virtus Fund Advisers's ABBV Position: Q4 2017 in Review

Virtus Fund Advisers held its AbbVie (ABBV) position steady in Q4 2017 at 5,555 shares worth $537K. The position accounts for 0.01% of the portfolio, ranked #323.

Virtus Fund Advisers first reported a position in ABBV in Q2 2014 and has held it in 15 quarters since. The position peaked at $1.06M in Q2 2014. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Virtus Fund Advisers held 5,555 shares of AbbVie worth $537K as of Q4 2017.
  • Virtus Fund Advisers left its AbbVie share count unchanged in Q4 2017.
  • AbbVie made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #323 holding.
  • Virtus Fund Advisers first reported a position in AbbVie in Q2 2014 and has held it in 15 quarters since.
  • Virtus Fund Advisers's AbbVie position peaked at $1.06M in Q2 2014.
  • 2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.